CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 23, 2001

Primary Completion Date

August 1, 2005

Study Completion Date

June 7, 2012

Conditions
Non-Hodgkins Lymphoma
Interventions
DRUG

CHOP/Rituximab

"Six cycles of CHOP/Rituximab therapy at 21-day intervals. CHOP chemo will be administered on day 1 after rituximab.~Cyclophosphamide750mg/m2 IV, Doxorubicin 50mg/m2 IV, Vincristine 1.4mg/m2 (max 2mg) IV, Prednisone 100mg PO daily x 5 days Rituximab 375mg/m2"

DRUG

PEG INTRON

Pegylated Interferon-alpha 2mg/kg/week for 52 weeks

Trial Locations (1)

68198

Unversity of Nebraska Medical Center, Omaha

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

University of Nebraska

OTHER

NCT00574730 - CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter